Small molecule · developed by Merck Sharp & Dohme LLC
B10 L-BPA is a boron-containing compound, a boronophenylalanine in which 10B replaces a position on L-phenylalanine, administered as an injection. It is used in boron neutron capture therapy (BNCT), in which neutron irradiation follows administration. It is studied in head and neck cancer and malignant brain tumors.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07003139 | Phase 1/2 | Malignant Brain Tumors | Recruiting | HRTX |
| NCT06952868 | Phase 2 | Head and Neck Cancer | Recruiting | HRTX |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Boron Neutron Capture TherapyHead and Neck CancerMalignant Brain Tumors